Table 2:

Outcomes, overall and in waves 1, 2 and 3

VariableNo. (%) of patients*
Overall
n = 1337
Wave 1
n = 520
Wave 2
n = 572
Wave 3
n = 245
28-day mortality207 (15.5)95 (18.3)93 (16.3)19 (7.8)
In-hospital death238 (17.8)111 (21.3)103 (18.0)24 (9.8)
Admitted to intensive care unit495/1336 (37.1)201 (38.7)215 (37.6)79/244 (32.4)
Organ support during hospital stay
 All patients
  Invasive mechanical ventilation281 (21.0)130 (25.0)116 (20.3)35 (14.3)
  Renal replacement therapy or dialysis68/1320 (5.2)33/511 (6.5)30/567 (5.3)5/242 (2.1)
  Vasopressor285 (21.3)120 (23.1)123 (21.5)42 (17.1)
 Patients admitted to intensive care unit
  Invasive mechanical ventilation276/495 (55.8)130/201 (64.7)111/215 (51.6)35/79 (44.3)
  Renal replacement therapy or dialysis49/484 (10.1)25/193 (13.0)20/213 (9.4)4/78 (5.1)
  Vasopressor276/495 (55.8)118/201 (58.7)117/215 (54.4)41/79 (51.9)
Organ support during first 14 d
 Invasive mechanical ventilation275 (20.6)127 (24.4)115 (20.1)33 (13.5)
 Renal replacement therapy or dialysis55/1315 (4.2)26/508 (5.1)24/565 (4.2)5/242 (2.1)
 Vasopressor278/1335 (20.8)116 (22.3)121/571 (21.2)41/244 (16.8)
DAF of invasive mechanical ventilation during first 14 d, mean ± SD10.8 ± 5.4
n = 1330
10.0 ± 5.9
n = 518
11.0 ± 5.3
n = 570
12.2 ± 4.3
n = 242
DAF of renal replacement therapy during first 14 d, mean ± SD12.2 ± 4.6
n = 1319
11.8 ± 5.0
n = 509
12.3 ± 4.5
n = 567
13.1 ± 3.4
n = 243
DAF of vasopressor first 14 d, mean ± SD11.3 ± 5.1
n = 1331
10.7 ± 5.5
n = 518
11.3 ± 5.0
n = 570
12.4 ± 3.9
n = 243
Hospital length of stay, d
 Survivors
  Median (IQR)9.0 (5.0–19.0)13.0 (7.0–25.0)8.0 (5.0–15.0)9.0 (5.0–15.0)
  Range2.0–135.02.0–135.02.0–77.02.0–66.0
 Decedents
  Median (IQR)11.0 (6.0–20.0)11.0 (6.0–21.0)11.0 (7.0–20.0)12.0 (9.5–24.0)
  Range0.0–63.00.0–63.01.0–44.02.0–62.0
Intensive care unit length of stay, d
 Survivors
  Median (IQR)8.0 (4.0–14.0)10.0 (4.0–17.0)7.0 (4.0–11.0)7.0 (2.0–13.5)
  Range0.0–86.00.0–86.01.0–39.01.0–54.0
 Decedents
  Median (IQR)14.0 (6.0–24.0)15.0 (5.0–26.0)12.0 (7.0–21.0)16.0 (10.0–49.0)
  Range0.0–61.00.0–61.00.0–38.03.0–57.0
  • Note: DAF = days alive and free, IQR = interquartile range, SD = standard deviation.

  • * Except where noted otherwise.

  • Patients who were discharged alive before day 28 and were lost to follow-up were assumed to be survivors at day 28 (n = 185, 177 and 81 for waves 1, 2 and 3, respectively).